Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oropharyngeal Leak Pressure of the SaCoVLM Video Laryngeal Mask Compared With LMA Supreme and Ambu AuraGain in Paediatric Patients Undergoing General Anaesthesia: A Multicentre Randomised Controlled Trial

NCT07891832 is registered in ClinicalTrials.gov with Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07891832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Oropharyngeal Leak Pressure of the SaCoVLM Video Laryngeal Mask Compared With LMA Supreme and Ambu AuraGain in Paediatric Patients Undergoing General Anaesthesia: A Multicentre Randomised Controlled Trial
Lead sponsor
Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
July 31, 2027
Enrollment
135 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

airway management, anesthesia, general, pediatric anesthesia

Arms

As registered; 3 arms.

  • SaCoVLM ExperimentalSaCoVLM video laryngeal mask

    Children randomised to airway management with the SaCoVLM video laryngeal mask, with video-guided verification and adjustment of device position.

  • LMA Supreme Active comparatorLMA Supreme

    Children randomised to airway management with the LMA Supreme, inserted using the standard blind technique.

  • Ambu AuraGain Active comparatorAmbu AuraGain

    Children randomised to airway management with the Ambu AuraGain, inserted using the standard blind technique.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Oropharyngeal leak pressure (OLP) From device insertion up to 5 minutes after insertion

    Airway pressure (cmH2O) at which the circuit manometer reading becomes stable, measured with the breathing circuit in manual mode, ventilation paused, fresh gas flow 10 L/min and the APL valve set to 50 cmH2O, after stable ventilation is achieved.

Lead sponsor's other trials

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s., most recent start first.